Every article, presentation, spotlight, and news item we've tagged to Longevity Services & Practice.
Showing 73–96 of 150
Isaac Health and NYU Langone have established a telehealth partnership to accelerate access to dementia and cognitive evaluation services, addressing critical delays in specialist availability across New York state. The hybrid model reduces diagnostic timelines from months to days while maintaining the option for in-person intervention when clinically indicated.
Researchers developed a genetic algorithm-based frailty index using nine years of longitudinal data from the China Health and Retirement Longitudinal Study to predict mortality and falls risk in aging adults. This computational approach identifies which physiological and functional markers most reliably indicate vulnerability to adverse outcomes, providing a data-driven alternative to subjective clinical assessment.
Loyal has raised $100 million in Series C funding as its lead candidate LOY-002, designed to extend healthy lifespan in dogs, approaches FDA Expanded Conditional Approval. The company has completed two of three major technical requirements and enrolled over 1,300 dogs in its pivotal STAY trial, positioning the first potential FDA-approved longevity drug for market readiness.
An autonomous laboratory system combining GPT-5 reasoning with Ginkgo's cloud infrastructure executed over 36,000 cell-free protein synthesis experiments in six months, reducing production costs by 40% while maintaining experimental rigor. This approach addresses a primary constraint in longevity research: the ability to test sufficient hypotheses at scale and speed without proportional increases in cost and human labor.
Point-of-care lung ultrasound and integrated respiratory monitoring technologies enable early detection of age-related pulmonary decline outside hospital settings, shifting care delivery toward prevention and functional preservation in aging populations. This decentralization of respiratory assessment addresses a critical gap in longevity care: the ability to identify declining respiratory capacity before symptomatic disease emerges.
Primary care and aging services collaboration can systematically identify and address social determinants affecting older adults' health outcomes. Integration between healthcare and community resources improves detection and intervention for unmet needs that directly influence aging trajectories.
20/20 BioLabs has licensed ROKIT Healthcare's chronic kidney disease prediction algorithm to integrate into its OneTest for Longevity platform, which measures inflammatory biomarkers as indicators of biological resilience. CKD affects over 35 million Americans, and early identification through biomarker profiling enables earlier intervention and risk stratification.
Humanaut is opening a Dallas clinic in May 2026 and offering founding memberships at a locked rate of $2,700 annually, which includes comprehensive biomarker assessments, body composition tracking, cardiovascular imaging, and access to therapeutic modalities such as hyperbaric oxygen and cryotherapy. This represents an expansion of a clinic-based longevity model that integrates baseline measurement with targeted interventions.
Noom acquired Tailor Made Compounding, a licensed 503A pharmacy operating across 46 states, to integrate prescription-grade therapies with behavioral coaching and establish a comprehensive preventive care platform. This move positions the company to expand beyond weight management into broader healthy aging interventions including peptide therapies and metabolic support.
A model integrating evolving, personalized care within existing seniors' residences supports aging in place by addressing changing assistance needs while maintaining community connection. This approach bridges the gap between independent living and institutional care, reducing fragmentation in service delivery for older adults.
Serotonin Centers opened its first Illinois location in Naperville, offering physician-led hormone optimization, medical weight management, and aesthetic services within a concierge model. The expansion reflects growing demand for medically supervised longevity and preventive health services in major metropolitan markets.
AEON Clinic in Dubai offers physician-supervised IV nutrient therapies and NAD+ treatments as part of a broader shift toward personalized health optimization focused on healthspan rather than lifespan. The clinic positions these interventions within longer-term health strategies rather than as standalone wellness experiences, reflecting emerging sophistication in how longevity medicine is being integrated into clinical practice.
The NUS Academy for Healthy Longevity is hosting a Geromedicine Conference in February 2026 to advance the clinical translation of geroscience research into practical interventions. The event will focus on implementing evidence-based strategies including targeted molecules, bioactive compounds, and repurposed pharmaceuticals within personalized care frameworks.
Human Longevity, Inc. and LEV Foundation are conducting multi-omic analyses of centenarians and supercentenarians to identify molecular biomarkers and pathways associated with exceptional longevity. This research bridges the gap between identifying what distinguishes the longest-lived individuals and developing interventions that could extend healthspan in broader populations.
Longevity escape velocity (LEV) describes the point at which medical interventions extend life faster than aging progresses, requiring a repair-based approach to cellular and molecular damage rather than slowing decline alone. De Grey argues that demonstrating rejuvenation success in animal models will shift scientific consensus and accelerate translation to human therapies.
Extreme longevity does not require genetic predisposition to exceptional health; rather, it emerges from multifactorial resilience combining protective genetics, metabolic efficiency, low systemic inflammation, and sustained lifestyle choices. This reframes centenarian health as an achievable outcome of integrated biological and environmental factors rather than an exceptional outlier.
Function Health positions comprehensive lab testing—160+ markers including metabolic and hormonal panels—as a foundation for preventive health monitoring, with emphasis on insulin, cortisol, thyroid, and leptin assessment to detect metabolic dysregulation earlier than standard screening. The model links biomarker tracking to lifestyle factors to inform individualized health optimization and support longitudinal monitoring.
This discussion reframes longevity from a pursuit of extreme lifespan extension toward a more grounded question: who benefits from living well longer, and under what conditions? The conversation bridges clinical evidence with ethical policy, arguing that longevity science should be evaluated by the same standards of safety, equity, and access applied to other medical fields.
Allen Law proposes that extending healthspan—not merely lifespan—is the central health challenge of the 21st century. The infrastructure and systems to support longer, stronger lives exist in scientific literature but remain inaccessible at scale; closing the 9.6-year gap between lifespan and healthspan requires proactive, preventive health built into daily life rather than reactive medicine.
The global biohacking market is projected to grow from US$38.05 billion in 2025 to US$216.68 billion by 2035, driven by consumer demand for self-tracking, personalized health optimization, and continuous sensing technologies. This expansion reflects a shift from consumer fitness gadgets toward clinical-grade diagnostics and subscription-based health management integrated into daily life.
Elitra Health launched a concierge primary care program limiting physician panels to 35 patients and offering 24/7 access, same-day appointments, and integrated preventive care coordination. The model prioritizes continuity of care and early detection through advanced diagnostics and personalized wellness planning as an alternative to volume-based primary care.
Human Longevity, Inc. and LEV Foundation are analyzing blood samples from centenarians and supercentenarians using multi-omic analysis to identify molecular and cellular patterns associated with exceptional longevity. This approach shifts the field from theoretical prediction toward evidence grounded in individuals who demonstrate sustained resilience across the human lifespan.
SRN-901, a five-component oral combination therapy, demonstrated a 33% increase in median lifespan and 70% reduction in frailty progression in mice, with preserved physical function and reduced tumor incidence. The multi-pathway approach contrasts with single-target interventions, suggesting that aging requires simultaneous modulation of interconnected biological processes rather than isolated molecular manipulation.
A new documentary translates geroscience research into accessible language for public audiences, emphasizing that lifestyle and environmental factors—not genetic destiny—are the primary drivers of aging outcomes. This shift from genetic determinism to behavioral agency represents a critical moment in moving longevity science from laboratory to practical application.
